maccura(SZ:300463) Zheng Quan Zhi Xing·2025-08-29 16:41Core Viewpoint - The announcement details a passive increase in the shareholding ratio of the controlling shareholders and their concerted actors of Maike Biological Co., Ltd., which has risen from 23.98% to 24.13% due to the repurchase and cancellation of restricted stock, without any change in the number of shares held [1][2][4]. Summary by Sections Shareholding Changes - The total share capital of the company decreased from 612,469,590 shares to 608,624,624 shares following the repurchase and cancellation of the first category of restricted stock under the 2024 incentive plan [1][2]. - The combined shareholding ratio of the controlling shareholders, including Tang Yong, Wang Dengming, and Liu Qilin, increased from 23.98% to 24.13%, reaching a whole number increment of 1% [1][2]. Impact on Governance - This change in shareholding does not involve any increase or decrease in the number of shares held by shareholders and will not lead to a change in the company's control or governance structure [2][3]. - The announcement confirms that the rights change will not affect the company's ongoing operations [2][4]. Details of Shareholders - The controlling shareholders and their concerted actors collectively hold 14,684,949.96 shares, which is 24.13% of the total share capital post-adjustment [3][4]. - The breakdown of shareholdings includes specific amounts held by each controlling shareholder, with Tang Yong holding 6,806,230.01 shares (11.19%), Wang Dengming holding 4,553,449.50 shares (7.48%), and Liu Qilin holding 3,312,736.00 shares (5.44%) [3].